Development of an AI Model for Predicting Methacholine Bronchial Provocation Test Results Using Spirometry

利用肺功能仪开发预测乙酰甲胆碱支气管激发试验结果的人工智能模型

阅读:3

Abstract

Background/Objectives: The methacholine bronchial provocation test (MBPT) is a diagnostic test frequently used to evaluate airway hyper-reactivity. MBPT is essential for diagnosing asthma; however, it can be time-consuming and resource-intensive. This study aimed to develop an artificial intelligence (AI) model to predict the MBPT results using forced expiratory volume in one second (FEV(1)) and bronchodilator test measurements from spirometry. Methods: a dataset of spirometry measurements, including Pre- and Post-bronchodilator FEV(1), was used to train and validate the model. Results: Among the evaluated models, the multilayer perceptron (MLP) achieved the highest area under the curve (AUC) of 0.701 (95% CI: 0.676-0.725), accuracy of 0.758, and an F1-score of 0.853. Logistic regression (LR) and a support vector machine (SVM) demonstrated comparable performance with AUC values of 0.688, while random forest (RF) and extreme gradient boost (XGBoost) achieved slightly lower AUC values of 0.669 and 0.672, respectively. Feature importance analysis of the MLP model identified key contributing features, including Pre-FEF(25-75) (%), Pre-FVC (L), Post FEV(1)/FVC, Change-FEV(1) (L), and Change-FEF(25-75) (%), providing insight into the interpretability and clinical applicability of the model. Conclusions: These results highlight the potential of the model to utilize readily available spirometry data, particularly FEV(1) and bronchodilator responses, to accurately predict MBPT results. Our findings suggest that AI-based prediction can improve asthma diagnostic workflows by minimizing the reliance on MBPT and enabling faster and more accessible assessments.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。